{"title":"成年急性早幼粒细胞白血病患者的血栓栓塞:临床特征、危险因素和预测图。","authors":"Lixia Hao, Yifan Yao, Linhua Yang","doi":"10.1007/s00277-025-06251-y","DOIUrl":null,"url":null,"abstract":"<div><p>Acute promyelocytic leukemia (APL) is typically associated with bleeding, whereas thromboembolism (TE) is a less common cause of early death (ED) and frequently underestimated complication. To investigate the clinical characteristics and predictive risk factors for TE, we conducted this retrospective study. Our study included 306 patients diagnosed with APL at the Second Hospital of Shanxi Medical University between May 2012 and May 2023. Among them, 16(5.2%) patients (11 males and 5 females, with a median age of 58 years) experienced TE, including 13 cases of arterial TE (10 cerebral infarctions and three myocardial infarctions), one case of combined arterial and venous TE, and two cases of venous TE. Multivariate logistic regression analysis revealed age (OR 1.08, 95% CI 1.03–1.13, <i>p</i> = 0.001), smoking (3.26, 1.01–10.49, <i>p</i> = 0.048), alkaline phosphatase (ALP) > 125U/L (10.8, 2.26–51.46, <i>p</i> = 0.021), and serum creatinine (SCr) > 62µmol/L (7.09, 1.35–37.35, <i>p</i> = 0.003) as independent risk factors for TE in newly diagnosed APL patients. A nomogram incorporating the four aforementioned predictive factors demonstrated high accuracy and clinical applicability. With a median follow-up of 6.6 years (range: 0.6–11.8 years), the overall survival (OS) rate for all patients was 86.2%. When excluding patients who succumbed to ED, the OS rate increased to 96.2%. Importantly, there was no statistically significant difference in OS rates between non-ED patients with and without TE (<i>p</i> = 0.405). Our findings underscore that age, smoking, ALP, and SCr are four independent risk factors for TE in APL. Furthermore, TE primarily affects early survival but not OS rates in APL patients.</p></div>","PeriodicalId":8068,"journal":{"name":"Annals of Hematology","volume":"104 2","pages":"973 - 983"},"PeriodicalIF":2.4000,"publicationDate":"2025-02-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://link.springer.com/content/pdf/10.1007/s00277-025-06251-y.pdf","citationCount":"0","resultStr":"{\"title\":\"Thromboembolism in adult patients with acute promyelocytic leukemia: clinical characteristics, risk factors, and a predictive nomogram\",\"authors\":\"Lixia Hao, Yifan Yao, Linhua Yang\",\"doi\":\"10.1007/s00277-025-06251-y\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>Acute promyelocytic leukemia (APL) is typically associated with bleeding, whereas thromboembolism (TE) is a less common cause of early death (ED) and frequently underestimated complication. To investigate the clinical characteristics and predictive risk factors for TE, we conducted this retrospective study. Our study included 306 patients diagnosed with APL at the Second Hospital of Shanxi Medical University between May 2012 and May 2023. Among them, 16(5.2%) patients (11 males and 5 females, with a median age of 58 years) experienced TE, including 13 cases of arterial TE (10 cerebral infarctions and three myocardial infarctions), one case of combined arterial and venous TE, and two cases of venous TE. Multivariate logistic regression analysis revealed age (OR 1.08, 95% CI 1.03–1.13, <i>p</i> = 0.001), smoking (3.26, 1.01–10.49, <i>p</i> = 0.048), alkaline phosphatase (ALP) > 125U/L (10.8, 2.26–51.46, <i>p</i> = 0.021), and serum creatinine (SCr) > 62µmol/L (7.09, 1.35–37.35, <i>p</i> = 0.003) as independent risk factors for TE in newly diagnosed APL patients. A nomogram incorporating the four aforementioned predictive factors demonstrated high accuracy and clinical applicability. With a median follow-up of 6.6 years (range: 0.6–11.8 years), the overall survival (OS) rate for all patients was 86.2%. When excluding patients who succumbed to ED, the OS rate increased to 96.2%. Importantly, there was no statistically significant difference in OS rates between non-ED patients with and without TE (<i>p</i> = 0.405). Our findings underscore that age, smoking, ALP, and SCr are four independent risk factors for TE in APL. Furthermore, TE primarily affects early survival but not OS rates in APL patients.</p></div>\",\"PeriodicalId\":8068,\"journal\":{\"name\":\"Annals of Hematology\",\"volume\":\"104 2\",\"pages\":\"973 - 983\"},\"PeriodicalIF\":2.4000,\"publicationDate\":\"2025-02-18\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://link.springer.com/content/pdf/10.1007/s00277-025-06251-y.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Annals of Hematology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://link.springer.com/article/10.1007/s00277-025-06251-y\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"HEMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of Hematology","FirstCategoryId":"3","ListUrlMain":"https://link.springer.com/article/10.1007/s00277-025-06251-y","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0
摘要
急性早幼粒细胞白血病(APL)通常与出血相关,而血栓栓塞(TE)是早期死亡(ED)的一个不太常见的原因,也是经常被低估的并发症。为了研究TE的临床特征和预测危险因素,我们进行了这项回顾性研究。我们的研究纳入了2012年5月至2023年5月在山西医科大学第二医院诊断为APL的306例患者。其中16例(5.2%)患者(男11例,女5例,中位年龄58岁)发生TE,其中动脉TE 13例(脑梗死10例,心肌梗死3例),动脉和静脉合并TE 1例,静脉TE 2例。多因素logistic回归分析显示,年龄(OR 1.08, 95% CI 1.03 ~ 1.13, p = 0.001)、吸烟(3.26,1.01 ~ 10.49,p = 0.048)、碱性磷酸酶(ALP) > 125U/L (10.8, 2.26 ~ 51.46, p = 0.021)、血清肌酐(SCr) > 62µmol/L (7.09, 1.35 ~ 37.35, p = 0.003)是新诊断APL患者TE的独立危险因素。结合上述四种预测因素的图显示出较高的准确性和临床适用性。中位随访6.6年(范围0.6-11.8年),所有患者的总生存率(OS)为86.2%。当排除死于ED的患者时,总生存率增加到96.2%。重要的是,非ed患者合并TE和不合并TE的OS率无统计学差异(p = 0.405)。我们的研究结果强调,年龄、吸烟、ALP和SCr是APL患者TE的四个独立危险因素。此外,TE主要影响APL患者的早期生存,而非OS率。
Thromboembolism in adult patients with acute promyelocytic leukemia: clinical characteristics, risk factors, and a predictive nomogram
Acute promyelocytic leukemia (APL) is typically associated with bleeding, whereas thromboembolism (TE) is a less common cause of early death (ED) and frequently underestimated complication. To investigate the clinical characteristics and predictive risk factors for TE, we conducted this retrospective study. Our study included 306 patients diagnosed with APL at the Second Hospital of Shanxi Medical University between May 2012 and May 2023. Among them, 16(5.2%) patients (11 males and 5 females, with a median age of 58 years) experienced TE, including 13 cases of arterial TE (10 cerebral infarctions and three myocardial infarctions), one case of combined arterial and venous TE, and two cases of venous TE. Multivariate logistic regression analysis revealed age (OR 1.08, 95% CI 1.03–1.13, p = 0.001), smoking (3.26, 1.01–10.49, p = 0.048), alkaline phosphatase (ALP) > 125U/L (10.8, 2.26–51.46, p = 0.021), and serum creatinine (SCr) > 62µmol/L (7.09, 1.35–37.35, p = 0.003) as independent risk factors for TE in newly diagnosed APL patients. A nomogram incorporating the four aforementioned predictive factors demonstrated high accuracy and clinical applicability. With a median follow-up of 6.6 years (range: 0.6–11.8 years), the overall survival (OS) rate for all patients was 86.2%. When excluding patients who succumbed to ED, the OS rate increased to 96.2%. Importantly, there was no statistically significant difference in OS rates between non-ED patients with and without TE (p = 0.405). Our findings underscore that age, smoking, ALP, and SCr are four independent risk factors for TE in APL. Furthermore, TE primarily affects early survival but not OS rates in APL patients.
期刊介绍:
Annals of Hematology covers the whole spectrum of clinical and experimental hematology, hemostaseology, blood transfusion, and related aspects of medical oncology, including diagnosis and treatment of leukemias, lymphatic neoplasias and solid tumors, and transplantation of hematopoietic stem cells. Coverage includes general aspects of oncology, molecular biology and immunology as pertinent to problems of human blood disease. The journal is associated with the German Society for Hematology and Medical Oncology, and the Austrian Society for Hematology and Oncology.